Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in Females
Launched by ALEXANDRIA UNIVERSITY · Apr 3, 2017
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
The investigators randomized 30 women with OAB, in two groups: G I (15 patients) received 30 minutes TPTNS, three times a week; GII (15 patients) received TPTNS plus Low dose trospium chloride (20 mg once daily); all for 8 weeks. Patients were evaluated using Overactive Bladder Symptom Score questionnaire (OABSS), Incontinence Impact Questionnaire-short form 7 (IIQ-7), 3 day voiding diary and urodynamics at weeks 0 and 8.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Thirty adult female patients having OAB symptoms (wet type) and proved to have detrusor overactivity by urodynamics
- Exclusion Criteria:
- • 1. Patients having urinary tract infection or bladder outlet obstruction.
- • 2. Patients having neurological diseases.
- • 3. Patients having gynecological problems as genital infection, pelvic organ prolapse or genital tumors.
- • 4. Patients with electronic implants such as heart pacemakers.
- • 5. During pregnancy
- • 6. Patients subject to seizures
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials